ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr. Director, Central Estimating & Planning at Eli Lilly and Company - ApplyBlast

Sr. Director, Central Estimating & Planning

Eli Lilly and Company

20 days ago

4.0 on Glassdoor

Indianapolis, Indiana, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Sr. Director, Central Estimating & Planning leads the Capital Portfolio Operations team within Global Facilities Delivery, owning the capital estimate and planning strategy for a $65 billion portfolio. This role establishes estimating and planning methodologies, validates cost and schedule outcomes, and manages stakeholder relationships to ensure accurate cost predictability. The position involves building and leading a team of estimators while aligning practices with global project controls frameworks.

Responsibilities

Own capital estimates from initial concept through project closeout
Establish estimating and planning strategy for capital portfolio
Build and lead Central Estimating & Planning team

Skills

Qualifications

Bachelor's degree in Engineering, Construction Management, or a related fieldCertified Cost Professional (CCP)Certified Estimating Professional (CEP)PMP certification

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.